Bethea ED, Chen Q, Hur C, et al. Cost-effectiveness of Treating Acute versus Chronic Hepatitis C Infection Using Direct-Acting Antivirals. AASLD 2017, abstract 24.
Pegozafermine doeltreffend tegen fibrose bij NASH in fase IIb-studie
jan 2024 | Hepatologie